<DOC>
	<DOCNO>NCT02690610</DOCNO>
	<brief_summary>This prospective study include 30 patient hilar/mediastinal lymph node detect thoracic CT either know lung malignancy ( stag purpose ) ( diagnose purpose ) . All patient undergo ROSE EBUS-guided TBNA . Mediastinoscopy invasive procedure perform EBUS-guided TBNA n't provide representative material .</brief_summary>
	<brief_title>Value Rapid Site Evaluation During EBUS-guided TBNA Diagnosis Mediastinal Lesions</brief_title>
	<detailed_description>All patient subject follow parameter : 1 . Thorough history take full clinical examination . 2 . Chest X-ray ( postro-anterior lateral view ) procedure . 3 . Recent Computed Tomography ( CT chest ) contrast . 4 . Laboratory study : - Complete liver function . - Blood urea serum creatinine . - Complete blood picture ( include platelet count ) . - Erythrocyte sedimentation rate ( ESR ) . - Fasting postprandial blood sugar . 5 . Preoperative evaluation : Pulmonary function test ( PFT ) , Electrocardiogram ( ECG ) , arterial blood gas ( ABG ) coagulation profile ( include bleed &amp; clot time , prothrombin time &amp; activity activate partial thromboplastin time ( APTT ) ) oral anticoagulant stop procedure least 48 hour . 6 . Color doppler ultrasound suspect vascular lesion . 7 . Clinical radiological follow patient 1 week procedure detect occurrence complication . 8 . The biopsy sample examine histopathologically . EBUS-TBNA do within 10 day CT examination local anesthesia conscious sedation . Convex Probe EBUS- Guided TBNA EBUS-guided TBNA examination perform Tanta University Educational Hospital Kobry Elkoba Military Hospital use Pantex EBUS probe Hitachi ultrasound supine position local anesthesia lidocaine conscious sedation . Lymph node identify accord Mountain 's regional lymph node classification system ( 17 ) . The lymph node station 2 , 4 , 7 , 10 11 evaluate systematically . During process every detect lymph node ; short long axis diameter , station lymph node , number pass per patient per lymph node record patient . N3 node sample first N2 node avoid contamination lung cancer patient . The material obtain EBUS-guided TBNA smear slide . These slide air-dried Diff-Quik ( American Scientific Products , McGaw Park , IL ) staining use ROSE . Additional smear prepare Papanicolaou stain remain sample place 10 % formalin histologic evaluation . The result ROSE compare result final pathologic diagnosis . ( 17 ) Aspiration specimen consider `` insufficient '' adequate number lymphocyte smear . Diagnosis `` malignant '' cytologic examination consider `` final diagnosis '' . For patient whose EBUS-guided TBNA result negative malignancy , invasive procedure mediastinoscopy do confirm diagnosis radiologic follow-up outcome LNs least 6 month . On follow-up , LNs persist size , diminish , resolve consider benign . A diagnosis tuberculosis sarcoidosis make base cytopathology show presence caseate noncaseating granuloma , addition clinical , radiological , microbiological finding . Any unexpected risk clear participant Ethics committee . Waste material dispose properly . All patient sign inform write consent . Patients ' name use replaced code number confirm privacy . Also , result study used scientific purpose .</detailed_description>
	<criteria>Hilar/mediastinal lymph node short axis 1 cm thoracic CT scan and/or PETCT suspicious malignancy without know lung malignancy . Hilar and/or mediastinal lymph node positive PET/CT scan without regard diameter suspicious malignancy . Recurrence restaging NSCLC chemotherapy radiation . Diagnosis lung cancer endobronchial lesion . Diagnosis benign ( especially tuberculosis sarcoidosis ) malignant mediastinal lesion ( eg . thymoma ) . Cardiovascular instability . Lack patient cooperation , e.g . intractable cough , inability remain motionless altered consciousness . Bleeding diathesis ( activate partial thromboplastin time ( APTT ) ratio international normalize ratio ( INR ) &lt; 1.3 platelet count &lt; 50000 per mm3 ) . Respiratory failure patient mechanical ventilation . Severe chronic obstructive pulmonary disease ( COPD ) ( FEV1 &lt; 1 liter &lt; 35 % predict ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>EBUS , Mediastinal lesion , Mediastinal lymph node</keyword>
</DOC>